Moreover, the IBS symptom score of anti-RIOK IgA positive IBS patients was higher than negative patients (10.5 ± 1.9 vs. 9.4 ± 1.6, p = 0.004). This evidence concerns the gene CD79A and irritable bowel syndrome.